Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective. Dermatology Reports, [S. l.], v. 16, n. 2, 2023. DOI: 10.4081/dr.2023.9839. Disponível em: https://journals.pagepress.org/dr/article/view/9839. Acesso em: 18 jun. 2025.